Search - tctmd.com

Displaying 1 - 20 of 661

Sort: Relevancy | Date

News Conference News ACC 2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

L.A. McKeown

April 08, 2026

News Conference News ACC 2026

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Michael O'Riordan

April 06, 2026

News Conference News ACC 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Yael L. Maxwell

April 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

L.A. McKeown

March 09, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Caitlin E. Cox

February 02, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

Todd Neale

January 07, 2026

News Daily News

Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes

Todd Neale

January 05, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

Advertisement

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

TCTMD’s Top 10 Most Popular Stories for March 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

March 2026 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

HF Care Differs Among Asian Subgroups in the US

January 2026 Dispatch for the CV Team

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FDA Approves Aficamten for Obstructive HCM

December 2025 Dispatch for the CV Team

Year in Review: Evidence Around AI in Cardiology Grows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content